Related Experiment Video
Updated: Jun 23, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Partnering for Care in HIV Prevention Trials
Kathleen M Macqueen1, Kerry McLoughlin, Patty Alleman
1Family Health International.
Summary
Researchers identified strategies to ensure health needs of HIV prevention study participants are met. This involves balancing direct care and referrals, ensuring quality healthcare, and engaging communities in "moral negotiation" for mutual benefits.
Area of Science:
- Global Health
- Medical Ethics
- Clinical Research
Background:
- HIV prevention research requires addressing participant health needs.
- Ensuring adequate healthcare for research participants is a complex ethical challenge.
- International research sites face unique logistical and ethical considerations.
Purpose of the Study:
- To identify strategies for addressing health needs of participants in HIV prevention research.
- To explore factors influencing healthcare provision within research settings.
- To understand the process of "moral negotiation" in global health research.
Main Methods:
- Qualitative case studies conducted at seven international research sites.
- Analysis of strategies for balancing direct care and healthcare referrals.
- Examination of factors affecting healthcare quality for research participants.
Main Results:
- Key factors identified for balancing direct care and healthcare referrals.
- Strategies for ensuring overall quality of healthcare for research participants.
- Demonstration of "moral negotiation" between researchers, communities, and host countries.
Conclusions:
- Effective strategies are crucial for meeting participant health needs in HIV prevention research.
- "Moral negotiation" is a vital process for achieving equitable benefits in global health research.
- Balancing research objectives with participant welfare requires careful planning and community engagement.
More Related Videos
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...